New psychoactive substances: a review and updates

A Shafi, AJ Berry, H Sumnall… - Therapeutic …, 2020 - journals.sagepub.com
New psychoactive substances (NPS) are a heterogeneous group of substances. They are
associated with a number of health and social harms on an individual and societal level …

Designer drugs: mechanism of action and adverse effects

D Luethi, ME Liechti - Archives of toxicology, 2020 - Springer
Psychoactive substances with chemical structures or pharmacological profiles that are
similar to traditional drugs of abuse continue to emerge on the recreational drug market …

An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using …

MK Laing, L Ti, A Marmel, S Tobias, AM Shapiro… - International Journal of …, 2021 - Elsevier
Background From mid-2018, an increase in novel psychoactive substance (NPS)
benzodiazepines was noted on surveillance of the unregulated drug market around …

[图书][B] Forensic chemistry

S Bell - 2022 - taylorfrancis.com
Forensic Chemistry, Third Edition, the new edition of this ground-breaking book, continues to
serve as the leading forensic chemistry text on the market. Fully updated, this edition …

Designer benzodiazepines: a review of toxicology and public health risks

P Brunetti, R Giorgetti, A Tagliabracci, MA Huestis… - Pharmaceuticals, 2021 - mdpi.com
The rising use of designer benzodiazepines (DBZD) is a cat-and-mouse game between
organized crime and law enforcement. Non-prohibited benzodiazepines are introduced onto …

Highly efficient dual-color luminophores for sensitive and selective detection of diclazepam based on MOF/COF bi-mesoporous composites

X An, D Jiang, Q Cao, F Xu, H Shiigi, W Wang… - ACS …, 2023 - ACS Publications
Currently, studies on electrochemiluminescence (ECL) mainly focused on the single
emission of luminophores while those on multi-color ECL were rarely reported. Here, a bi …

An expanding world of new psychoactive substances—designer benzodiazepines

JB Zawilska, J Wojcieszak - Neurotoxicology, 2019 - Elsevier
The abuse of new psychoactive substances (NPS) has been increasing dramatically since
the late 2000s worldwide. Between 2009 and 2017, a total of 803 individual NPS were …

Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects

AN Edinoff, CA Nix, AS Odisho, CP Babin… - Neurology …, 2022 - mdpi.com
As tranquilizers, benzodiazepines have a wide range of clinical uses. Recently, there has
been a significant rise in the number of novel psychoactive substances, including designer …

Progress in the development of TRPV1 small-molecule antagonists: Novel Strategies for pain management

K Zhu, L Wang, TT Liao, W Li, J Zhou, Y You… - European journal of …, 2023 - Elsevier
Transient receptor potential vanilloid 1 (TRPV1) channels are widely distributed in sensory
nerve endings, the central nervous system, and other tissues, functioning as ion channel …

'New/Designer Benzodiazepines': an analysis of the literature and psychonauts' trip reports

L Orsolini, JM Corkery, S Chiappini… - Current …, 2020 - ingentaconnect.com
Background: NPS belonging to the benzodiazepine (BZD) class, eg,'legal/designer
BZDs'/'research chemicals', have recently emerged in the drug (mainly online/virtual) market …